Subscribe To
NKGen Announces Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
SANTA ANA, Calif., May 25, 2023 (GLOBE NEWSWIRE) — NKGen Biotech Inc. (“NKGen”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapeutics, today announced an upcoming poster presentation by its parent company, NKMax Co., Ltd., on preclinical and clinical data from a Phase I/IIa […] The post NKGen Announces Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Ann...
Read More
Posted: May 25 2023, 17:05
Author Name: forextv
Views: 101921